Showing results (181-190 of 241) with videos related to

Sort By:
Pageof 25
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|March 18, 2006
Human microvascular endothelial cellular interaction with atomic N-doped DLC compared with Si-doped DLC thin filmsT I T Okpalugo, H Murphy, A A Ogwu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2010
Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancerPatrick D Maguire, Michael Papagikos, Sue Hamann, et al.
International Journal of Surgery (London, England)|August 12, 2016
Iatrogenic common bile duct injuries: Increasing complexity in the laparoscopic era: A prospective cohort studyN M Hogan, D Dorcaratto, A M Hogan, et al.
Malaria Journal|November 16, 2006
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, IndonesiaEdith R Lederman, Jason D Maguire, Iwa W Sumawinata, et al.
Haemostasis|January 1, 1981
The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in manE D Maguire, G F Pay, J Turney, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 24, 2006
Organ transplantation in hereditary apolipoprotein AI amyloidosisJ D Gillmore, A J Stangou, H J Lachmann, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2003
New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolatesHadya S Nagesha, Gerard J Casey, Karl H Rieckmann, et al.
Frontiers in Oncology|November 19, 2014
National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons LearnedRosemary S L Wong, Bhadrasain Vikram, Frank S Govern, et al.
Vaccine|February 15, 2022
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and olderJohannes Beeslaar, Susan Mather, Judith Absalon, et al.
Vaccine|December 28, 2021
A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adultsDaniel Drazan, Hanna Czajka, Jason D Maguire, et al.
Pageof 25